Table of contents
Impaired Driving and Workplace Safety
How regulation strengthens enforcement where it matters most.
Executive Summary
A lot of people hear drug legalization or drug policy reform and immediately jump to the same fear:
What about the road?
What about the job site?
What about the school bus driver, crane operator, nurse, lineman, pilot, trucker, and warehouse employee?
What about the boss who has to keep everyone alive?
That fear is legitimate.
It is also one of the strongest arguments for a regulated model instead of against it.
NHTSA says driving impaired by any substance is illegal in all 50 states and the District of Columbia, and CDC says cannabis can impair coordination, reaction time, judgment, and perception in ways that make driving dangerous.[1][2] DOT and SAMHSA also already run extensive drug-testing and return-to-duty systems for transportation and federal workplaces, which means the country is not starting from zero when it comes to safety sensitive jobs drug testing or workplace safety enforcement.[7][8][9]
The real question is not whether enforcement matters.
The real question is what gets enforced.
A regulated model lets the law focus less on simple possession and more on actual danger:
• drug impaired driving laws that target drivers who are unsafe behind the wheel
• cannabis workplace safety rules that protect co-workers and the public
• a workplace impairment policy that focuses on fitness for duty instead of vague moral theater
• a marijuana workplace policy that distinguishes off-duty adult use from on-duty impairment
• safety sensitive jobs drug testing that stays toughest where mistakes can kill people
That is the argument in this chapter.
Part 10 already made the case that regulation does not eliminate enforcement. It changes what gets enforced.
Part 19 showed that complicated drug administration systems already exist.
Part 26 showed how a regulated world protects youth and families through tighter rules, not weaker ones.
Part 27 extends the same logic to roads, job sites, and workplace safety: in a regulated world, enforcement becomes more targeted, more honest, and more defensible.
The Safety Question This Chapter Solves
The old drug-war frame treats every use question like the same question.
It is not.
There is a huge moral and legal difference between:
• adult off-duty use
• on-duty impairment
• driving while impaired
• violating a workplace impairment policy in a safety-critical role
• selling contaminated products
• diverting high-risk products outside legal channels
A system built on risk-based drug regulation can tell those differences more clearly than a system built mainly on blanket prohibition. That is exactly why regulation strengthens enforcement where it matters most.
It lets policymakers say, plainly:
• road safety rules stay strict
• public safety rules stay strict
• employers still have authority over dangerous impairment
• the highest-risk lane still belongs in a regulated pharmacy model, not broad retail
• diversion control still matters
• treatment on demand is available when someone is unsafe because of addiction, not just punished after the fact
That is not soft.
That is a better map of actual risk.
1. Drug Impaired Driving Laws Should Target Real Impairment
The first point needs to be blunt:
A regulated world does not legalize driving while high, sedated, buzzed, or drug-impaired.
NHTSA says drug-impaired driving is illegal everywhere in America and notes that alcohol, marijuana, opioids, methamphetamine, prescription medications, and over-the-counter drugs can all impair driving ability.[1] NHTSA’s countermeasures guide also explains that states use different models of drug impaired driving laws: some rely on impairment-based statutes, some use per se thresholds, and some use zero-tolerance rules for certain substances.[3]
That is the baseline.
The harder question is how to make drug impaired driving laws more effective.
CDC says acute cannabis use can slow reaction time, impair coordination, and distort perception, but it also says it is difficult to connect the presence of cannabis or a THC concentration to actual impairment in any single driver.[2] NHTSA’s broader overview makes the same point more generally: unlike alcohol, the relationship between drug levels in the body and actual driving impairment has not been established for drugs other than alcohol.[2][4]
That means good drug impaired driving laws have to do two things at once:
stay tough on actual unsafe driving
stay honest about the scientific limits of simple biological thresholds
This matters because if policymakers pretend there is a clean alcohol-style impairment number for THC, they will end up overclaiming certainty they do not actually have. But if they use that uncertainty as an excuse to do nothing, they leave the public exposed.
So smarter drug impaired driving laws should emphasize:
• officer observation
• field evidence of impairment
• crash and driving behavior evidence
• drug recognition expertise where available
• toxicology as supporting evidence, not magic truth serum
• stronger public messaging around delayed reaction time and judgment
That is not weaker enforcement. It is better enforcement.
A 2024 systematic review of traffic injuries after recreational cannabis legalization found mixed results across North America: four studies reported increases in traffic injuries, while three found no significant change. The authors said the mixed evidence still supported better training and preparedness around cannabis-related impairment.[15] Acute cannabis use can impair driving. The policy response should be serious, but it should also be scientifically honest.[2][15]
That is how drug impaired driving laws get stronger in a regulated world: by focusing on actual dangerous driving, not just symbolic drug-war posture.
2. Cannabis Workplace Safety Needs Rules, Not Slogans
The next fear people have is the workplace.
And again, the right answer is not denial. It is structure.
CDC/NIOSH says employers in all industries face challenges addressing cannabis use among workers, especially in safety-sensitive positions, and that changing cannabis laws and attitudes create new questions for worker health, safety, and well-being.[5] NIOSH also says the cannabis industry itself has chemical, biological, ergonomic, fire, explosion, slip, trip, fall, and workplace violence hazards that employers and workers need to manage through actual safety plans.[5][16]
That means cannabis workplace safety is bigger than one question about whether somebody smoked last weekend.
It includes:
• impairment risk in active duties
• job-site hazards in cannabis cultivation, processing, retail, and transport
• employer training
• reporting rules
• protective equipment and hazard controls
• safety-sensitive roles where any lapse can injure workers or the public
A serious cannabis workplace safety model therefore does not rely on vibes. It uses the same logic that safety law already uses elsewhere:
• identify the role
• identify the hazard
• match the rule to the hazard
• document the standard
• enforce consistently
That is why cannabis workplace safety belongs inside risk-based drug regulation. Some jobs are inherently higher risk than others. A forklift operator, train engineer, ER nurse, airline mechanic, and classroom teacher do not all require the same policy language. Regulation makes those distinctions easier to write down and defend.
And that matters politically too. Employers, unions, and families are much more likely to accept drug policy reform if they can see how cannabis workplace safety is actually being managed rather than hand-waved.
3. Workplace Impairment Policy Should Focus on Fitness for Duty
This is where the conversation usually gets sloppy.
People slide from “drug detected” to “worker unsafe” as if those are always the same thing.
NIOSH says they are not. Its cannabis-and-work bulletin explains that marijuana can be detected for days or even weeks after use, long after the individual has stopped experiencing impaired functioning, and that interpreting a positive urine drug test is therefore challenging.[6] NIOSH adds that impairment varies by dose, route, tolerance, and user experience, and that it is developing information on impairment testing as a potential adjunct or alternative to certain forms of workplace drug testing.[6]
That is why a serious workplace impairment policy cannot just be “zero thought plus urine test.”
A strong workplace impairment policy should focus on fitness for duty:
• Is the worker safe right now?
• Is the worker performing a safety-sensitive function?
• Is there behavioral or functional evidence of impairment?
• Is there a post-incident, reasonable-suspicion, or return-to-duty context?
• Is there a policy distinction between off-duty legal conduct and on-duty unsafe conduct?
This is not about letting people off the hook.
It is about making the hook attach to the right thing.
The research on cannabis and occupational injury is mixed. A 2020 systematic review found the existing evidence was insufficient to support a strong claim that cannabis users as a group are at higher risk of occupational injury, in part because studies often did not assess whether cannabis use preceded the injury event or whether actual impairment was present.[14] That is exactly why a workplace impairment policy should not confuse broad assumptions with safety science.[14]
So a good workplace impairment policy should be:
• tougher on actual impairment
• clearer about post-accident protocols
• clearer about reasonable suspicion
• stricter in high-risk roles
• less morally theatrical about lawful off-duty adult behavior in lower-risk roles
That is how employers protect workers without drifting into arbitrary enforcement.
4. Safety Sensitive Jobs Drug Testing Already Shows How Regulation Works
Anyone who says regulated safety systems are impossible has not looked at transportation law.
Safety sensitive jobs drug testing already exists at large scale.
SAMHSA says current HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs using urine took effect on February 1, 2024, and current oral-fluid guidelines took effect October 10, 2023. SAMHSA says these guidelines provide the scientific and technical structure for federal workplace drug testing and that they enhance public safety for positions where even a momentary lapse of attention or judgment could result in significant harm.[7] SAMHSA also says federal workplace testing is part of a broader drug-free workplace program and that federal agencies designate safety-related positions for random testing.[7][13]
DOT’s 49 CFR Part 40 describes required procedures for workplace drug and alcohol testing in federally regulated transportation industries.[8] DOT’s updated 2025 marijuana notice says marijuana remains unacceptable for safety-sensitive transportation employees until any rescheduling is complete and that DOT’s testing process and regulations are not changing in the meantime.[9]
This is what safety sensitive jobs drug testing looks like in practice:
• regulated testing procedures
• defined safety-sensitive roles
• mandatory record checks
• mandatory removal after certain violations
• defined return-to-duty processes
• confidential records rules
• continuing follow-up testing
DOT rule 40.23 says employers must immediately remove workers from safety-sensitive functions after a verified positive, adulterated, or substituted drug test result, and may not return them to safety-sensitive work until they complete the return-to-duty process.[10] DOT rule 40.25 says employers must check an employee’s prior drug and alcohol testing record before first using them in safety-sensitive duties, and FMCSA-regulated employers must use the Clearinghouse for this process.[11]
The FMCSA Clearinghouse shows the scale. As of January 1, 2025, the system had recorded 312,853 test results with violations since January 6, 2020. It showed 279,757 drivers with at least one violation, 180,667 drivers still in prohibited status, and 34,636 marijuana-metabolite positive tests reported in 2024 alone. Positive drug tests accounted for 81% of total violations.[12]
So safety sensitive jobs drug testing is not speculative. It is already how the United States handles impairment risk in transportation.
The smarter question is how to learn from it.
5. Marijuana Workplace Policy Should Separate Safety From Moral Theater
This is where employer policy often gets stuck between two bad choices:
• treat all cannabis use as equally disqualifying
• or pretend workplace impairment is too hard to address
Neither is serious.
SAMHSA says most private employers are not federally required to have a drug-free workplace policy, except federal contractors and grantees and certain safety- and security-sensitive industries or positions.[13] That means a lot of employers still have room to design a marijuana workplace policy that fits the actual risk profile of the work.
A stronger marijuana workplace policy should therefore distinguish between:
lawful off-duty adult behavior in lower-risk jobs
on-duty possession or use
actual impairment on the job
safety-sensitive duties where stricter rules are justified
post-incident and reasonable-suspicion testing situations
That is how marijuana workplace policy becomes more defensible. It stops being a culture-war statement and becomes a risk-management tool.
It also creates room for treatment on demand and smarter return-to-duty planning instead of only termination or permanent exclusion. DOT’s return-to-duty rules already point in that direction. Rule 40.293 says a Substance Abuse Professional must conduct a comprehensive assessment and recommend education or treatment designed, to the greatest extent possible, to protect public safety if the employee returns to safety-sensitive work. Rule 40.307 says the SAP establishes the written follow-up testing plan.[17][18]
That matters because a regulated system should not ask employers to choose between punishment and chaos. A good marijuana workplace policy can include:
• immediate removal from unsafe work when needed
• documented evaluation
• return-to-duty standards
• follow-up testing for higher-risk roles
• referral to care or employee assistance
• clearer expectations for supervisors and workers
That is where accountability becomes smarter.
And it is also where this chapter connects to the rest of the series. In a full risk-based drug regulation model, lower-risk adult products and behaviors are not handled the same way as the highest-risk lane. The highest-risk lane belongs in a regulated pharmacy model with tighter diversion control, more oversight, and clearer entry to treatment on demand when addiction is the underlying problem. That keeps the toughest rules where the danger is highest instead of smearing the same rule across everything.
6. Drug Impaired Driving Laws and Cannabis Workplace Safety Get Better When Enforcement Focuses on Actual Harm
The old model spends too much energy on possession and too little on function.
A regulated model flips that.
It says enforcement should be strongest where danger is greatest:
• on the road
• on the job site
• in safety-sensitive roles
• in youth access cases
• in contaminated-product cases
• in diversion and fraud cases
That is why drug impaired driving laws and cannabis workplace safety belong in the same chapter. They both improve when the law focuses on real-world risk rather than moral symbolism.
In practice, that means:
For roads
• better officer training
• clearer public messaging
• stronger crash investigation protocols
• better integration of behavioral evidence and toxicology
• tougher, more credible drugged driving prevention
For employers
• stronger supervisor training
• role-specific workplace impairment policy language
• clearer marijuana workplace policy distinctions
• tougher rules for safety sensitive jobs drug testing
• consistent post-incident and return-to-duty procedures
For the broader system
• more public safety attention on dangerous behavior
• more accountability for employers and operators
• more overdose prevention and treatment on demand for people whose impairment risk is part of a larger addiction crisis
That last point matters. Regulation does not only sharpen enforcement. It also creates pathways away from repeated danger. A worker or driver with a substance problem is not helped by a system that can only say “you’re out” and never “here is the next safe step.”
That is not weakness. That is how durable workplace safety gets built.
The Bottom Line
The choice is not between safety and reform.
The choice is between sloppy enforcement and smarter enforcement.
A regulated model does not weaken drug impaired driving laws. It clarifies them.
It does not make cannabis workplace safety optional. It makes it more explicit.
It does not make a workplace impairment policy harder to defend. It makes it easier to target actual unsafe performance.
It does not make marijuana workplace policy softer by default. It lets employers separate risk management from moral theater.
And it proves that safety sensitive jobs drug testing can remain toughest exactly where mistakes can kill people.
That is why regulation strengthens enforcement where it matters most:
• real impairment
• real danger
• real public safety
• real accountability
Frequently Asked Questions
Are drug impaired driving laws still strict in a regulated system?
Yes. Drug impaired driving laws stay strict because driving impaired by any substance remains illegal in all 50 states and D.C. The better question is how those laws can target real impairment more accurately.[1][3][4]
Why is cannabis workplace safety different from a general anti-drug policy?
Because cannabis workplace safety focuses on actual safety hazards, job function, and fitness for duty rather than broad moral claims about every off-duty user. NIOSH specifically says employers face challenges addressing cannabis among workers, especially in safety-sensitive jobs.[5][16]
What should a workplace impairment policy actually focus on?
A good workplace impairment policy should focus on on-duty impairment, reasonable suspicion, post-incident situations, and safety-sensitive functions, not just the bare fact that a test found a metabolite. NIOSH notes that THC can be detected long after impairing effects have ended.[6]
How should marijuana workplace policy handle safety-sensitive jobs?
A strong marijuana workplace policy should be strictest where a lapse can injure workers or the public. In federally regulated transportation, safety sensitive jobs drug testing already includes removal from duty, record checks, evaluation, and return-to-duty steps.[8][9][10][11][12][17][18]
Does workplace testing prove current impairment?
Not always. That is one reason safety sensitive jobs drug testing works best as part of a broader safety system that includes role-specific rules, observed behavior, record checks, and return-to-duty processes. Positive tests can be operationally important without being a perfect real-time impairment measure.[6][8]
How does this connect to the rest of the series?
It connects through risk-based drug regulation. Lower-risk adult behavior should not be enforced the same way as dangerous driving, unsafe on-duty performance, or the highest-risk lane. That higher-risk lane belongs in a regulated pharmacy model with tighter diversion control, stronger public safety rules, and clearer access to treatment on demand.
References
[1] National Highway Traffic Safety Administration. Drug-Impaired Driving. https://www.nhtsa.gov/risky-driving/drug-impaired-driving/nhtsa-action
[2] Centers for Disease Control and Prevention. Cannabis and Driving. https://www.cdc.gov/cannabis/health-effects/driving.html
[3] National Highway Traffic Safety Administration. Drug-Impaired-Driving Laws. https://www.nhtsa.gov/book/countermeasures-that-work/drug-impaired-driving/countermeasures/legislation-and-licensing/drug
[4] National Highway Traffic Safety Administration. Drug-Impaired Driving Overview. https://www.nhtsa.gov/book/countermeasures-that-work/drug-impaired-driving
[5] Centers for Disease Control and Prevention / NIOSH. Cannabis Use and Workers. https://www.cdc.gov/niosh/substance-use/cannabis/index.html
[6] Centers for Disease Control and Prevention / NIOSH. Cannabis and Work: Implications, Impairment, and the Need for Further Research. https://www.cdc.gov/niosh/bulletin/2020/cannabis-research.html
[7] Substance Abuse and Mental Health Services Administration. Frequently Asked Questions About Federal Workplace Drug Testing. https://www.samhsa.gov/substance-use/drug-free-workplace/faqs
[8] U.S. Department of Transportation. Procedures for Transportation Workplace Drug and Alcohol Testing Programs. https://www.transportation.gov/odapc/part40
[9] U.S. Department of Transportation. DOT’s Notice on Testing for Marijuana. https://www.transportation.gov/odapc/marijuana-notice
[10] U.S. Department of Transportation. 49 CFR Part 40 Section 40.23. https://www.transportation.gov/odapc/part40/40-23
[11] U.S. Department of Transportation. 49 CFR Part 40 Section 40.25. https://www.transportation.gov/odapc/part40/40-25
[12] Federal Motor Carrier Safety Administration. Clearinghouse Monthly Report – December 2024. https://clearinghouse.fmcsa.dot.gov/content/resources/Clearinghouse_MonthlyReport_December2024.pdf
[13] Substance Abuse and Mental Health Services Administration. Employer Resources: Federal Laws and Regulations. https://www.samhsa.gov/substance-use/drug-free-workplace/employer-resources/federal-laws
[14] Biasutti WR, Leffers KSH, Callaghan RC. Systematic Review of Cannabis Use and Risk of Occupational Injury. https://pubmed.ncbi.nlm.nih.gov/32441179/
[15] Dion PM, Lampron J, Rahmani M, et al. Road hazard: a systematic review of traffic injuries following recreational cannabis legalization. https://pubmed.ncbi.nlm.nih.gov/38951474/
[16] Centers for Disease Control and Prevention / NIOSH. Workplace Safety and Health Hazards | Cannabis. https://www.cdc.gov/niosh/cannabis/about/index.html
[17] U.S. Department of Transportation. 49 CFR Part 40 Section 40.293. https://www.transportation.gov/odapc/part40/40-293a
[18] U.S. Department of Transportation. 49 CFR Part 40 Section 40.307. https://www.transportation.gov/odapc/part40/40-307
If you want to follow the full series as it publishes, visit the full Drug Legalization Series. If you prefer audio conversations on recovery, reentry, and purpose, check the podcast page. For program directors building reentry and transition programming, see ReturnPath reentry curriculum. For the personal story behind this work, read A Vision of Hope. To invite Andrew for a keynote or panel, see speaking.